Search Results 1601-1610 of 15589 for Orange Peel tea

1. A Study of GDC-0449 and Erlotinib Hydrochloride, with or without Gemcitabine Hydrochloride for Treating Patients with Metastatic Pancreatic Cancer or Solid Tumors that cannot be Removed by Surgery - Mayo Clinic

   Active other malignancy, excepting non-melanotic skin cancer or carcinoma-in-situ of the cervix. If a history of prior malignancy, must not be receiving ...

2. Combination Therapy Of Pegylated Interferon Alfa-2a And Tenofovir Versus Tenofovir Monotherapy In Chronic Hepatitis B - Mayo Clinic

   ... skin). Expected need for ongoing use of any antivirals with activity against HBV during the course of the study. Participation in any other clinical trial ...

3. A Study Of Ibrutinib With Rituximab In People With Untreated Marginal Zone Lymphoma - Mayo Clinic

   The purpose of this study is to see if the combination of rituximab and ibrutinib can help people with marginal zone lymphoma who have not received treatment in ...

4. A Study Of IMO-2125 In Combination With Ipilimumab Versus Ipilimumab Alone In Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301) - Mayo Clinic

   Subjects with another primary malignancy that has not been in remission for at least 3 years with the exception of non-melanoma skin cancer, curatively ...

5. A Study To Evaluate Pembrolizumab For Surgically Treated Adjuvant Merkel Cell Carcinoma - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

6. A Study To Evaluate Gemcitabine Hydrochloride And Cisplatin With Or Without Nab-Paclitaxel In Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers - Mayo Clinic

   No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer ...

7. A Study Of X4P-001 In Patients With Advanced Renal Cell Carcinoma - Mayo Clinic

   Completely resected basal cell and squamous cell skin cancers;; Any malignancy considered to be indolent and that has never required therapy;; Completely ...

8. A Study To Evaluate Androgen-Deprivation Therapy And Radiation Therapy In Treating Patients With Prostate Cancer - Mayo Clinic

   No prior invasive (except non-melanoma skin cancer) malignancy unless disease-free for a minimum of 3 years (1,095 days) and not in the pelvis; e.g. ...

9. A Study To Evaluate The Safety And Effectiveness Of TEPEZZA® In Treating Patients With Chronic (Inactive) Thyroid Eye Disease - Mayo Clinic

   The primary purpose of this study is to investigate the effectiveness, safety and tolerability of TEPEZZA® (teprotumumab-trbw) in comparison to placebo in ...

10. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma - Mayo Clinic

    RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as rituximab, can ...